24 May 2013
Keywords: merck, serono, buys, bionomics, ms, drug, licensing
Article | 30 June 2008
In a licensing and development deal with Australia's Bionomics, Switzerland-based Merck Serono, part of German drug major Merck KGaA,
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 June 2008
© 2013 thepharmaletter.com